MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1114.14

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.25M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 140.35B
A Agilent Technologies Inc

N/A

USD 32.44B
IQV IQVIA Holdings Inc

N/A

USD 24.71B
LH Laboratory Corporation of Amer..

N/A

USD 20.88B
DGX Quest Diagnostics Incorporated

N/A

USD 19.12B
QGEN Qiagen NV

N/A

USD 9.05B
CRL Charles River Laboratories

N/A

USD 6.92B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
TMO Thermo Fisher Scientific Inc

N/A

N/A
WAT Waters Corporation

N/A

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

N/A

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 5.43B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.95% 67% D+ 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.95% 67% D+ 21% F
Trailing 12 Months  
Capital Gain -24.70% 58% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.70% 58% F 12% F
Trailing 5 Years  
Capital Gain 48.89% 73% C 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.89% 73% C 46% F
Average Annual (5 Year Horizon)  
Capital Gain 7.82% 83% B 65% D
Dividend Return 7.82% 83% B 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.84% 67% D+ 39% F
Risk Adjusted Return 31.47% 83% B 49% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike